Latin America Methadone Market Research Report - Segmented By Application, Mode Of Administration & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2024 to 2029)

Updated On: January, 2024
ID: 6498
Pages: 145

Latin America Methadone Market Size & Growth (2023 to 2028)

As per the research report, the size of the Latin America Methadone Market was valued at USD xx Million in 2023 and estimated to be growing at a CAGR of xx%, to reach USD xx Million by 2028 during the forecast period 2023 to 2028.

The increasing incidence of chronic illnesses and the high prevalence of opioid abuse are likely to contribute to the growth of the Latin American methadone market. According to WHO, chronic diseases are the leading cause of premature death and disability across many countries. In 2015, 45% of deaths among men and women under 70 were responsible for two out of three deaths in the total population.

Methadone maintenance therapy has reduced the transmission of blood viruses associated with injecting opioids, such as hepatitis B, hepatitis C, or HIV. The primary aim of methadone maintenance therapy is to relieve cravings for opioid use, reduce withdrawal symptoms, and suppress the euphoric effects caused by opioids. Chronic extended administration of methadone will lead to neuroadaptation, which results in tolerance and withdrawal syndrome.

However, when used correctly in treatment, maintenance therapy is medically safe, non-sedating, and can slow recovery from opioid addiction. Currently, methadone is widely used in pregnant women dependent on opioids. However, it is expected to find niche growth in the studied market during the years to come.

Acute encephalopathy is detected in methadone intoxicated patients, where an MRI of the brain is beneficial for detecting methadone-induced encephalopathy. The increasing dominance of this disease among young people and the improving medical facilities for drug-abuse people are also driving the growth of this market. In addition, the increase in drug-related R&D activities, the growing number of people addicted to various opioids such as heroin and morphine, etc., increased awareness and adoption of methadone for pain management will positively impact the Latin American methadone market during the period 2023 - 2028.

The adverse effects of methadone are identical to those of other opioids, such as constipation, dizziness, drowsiness, abnormal heart rhythms, vomiting, and sweating, and respiratory depression. The risks are more significant when associated with higher doses, even causing death. In addition, continuous use of methadone can be misused and lead to addiction. The number of deaths due to methadone infection increased from 3,300-4500 in 2015-2019. Due to all these factors, methadone is used under supervision and used only for a limited group of people; this may restrain the market. In addition, strict government approval will create substantial barriers to the Latin American methadone market growth.

This research report on the Latin America Methadone Market has been segmented and sub-segmented into the following categories:

By Application:

  • Operation
  • Detoxification
  • Others

By Mode Of Administration:

  • Injections
  • Oral Medicine

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, Latin American methadone market is predicted to be dominated by Brazil due to the increased prevalence of deaths and the increase in incidents of substance abuse by illicit drugs. According to the report released by the Centers for Disease Control and Prevention (CDC) in 2019, more than one in five adults struggled from chronic pain 2019. This region will have the most profitable margins during the forecast period due to the higher adoption rate of pain relievers in the healthcare industry.

While the Latin American market will experience steady growth, regional markets in Argentina, Mexico will have high CAGR due to the large elderly population suffering from co-morbidities, improving the healthcare system that supports medical tourism. However, Chile is expected to be the least rewarding business sector due to the lower adoption of methadone.


Prominent companies leading in the Latin American Methadone Market profiled in the report are Diskets, Methadoes, Aurolife Pharma LLC, Macfarlan Smith, VistaPharm, Qinghai Pharm, CentralPharm, Mallinckrodt, and Roxane (Boehringer Ingelheim) among others.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample